Synchron Secures $200M Series D, Plans New Brain Interface With ‘Potentially More Applications’

 
• By Marion Webb
  
Synchron raised $200m in a series D round, which will be used to fund pivotal trials and commercialization of its brain-computer interface Stentrode. The company is also develping its third-generation BCI. (Shutterstock)

More from Financing

More from Business